In a previous study of our group, we explored whether bnAbs against HIV-1 can prevent infection of the first cells after mucosal exposure to a challenge virus that uses HIV-1 Env for entry during the first replication cycle, but then switches to SIV Env usage [20]. The gene discussed is ERVW-1; the disease is infection.